AlveoGene Analysis: $3M Raised
What is AlveoGene?
Inhaled gene therapy for rare respiratory diseases
HQ Country
Oxford, United Kingdom
Employees
1-10
Founded
2022
HQ State/Province
England
Funding Category
Seed
HQ Full Address
46 Woodstock Rd, Oxford OX2 6HT, United Kingdom
Product Features & Capabilities
- Inhaled gene therapy solutions for rare respiratory diseases
